Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Early Access Phase IIIb Study of Trifluridine / Tipiracil (S 95005/TAS-102) in Patients With a Pretreated Metastatic Colorectal Cancer (PRECONNECT)

NCT03306394 is registered in ClinicalTrials.gov with Institut de Recherches Internationales Servier as lead sponsor.

NCT NCT03306394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03306394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Early Access Phase IIIb Study of Trifluridine / Tipiracil (S 95005/TAS-102) in Patients With a Pretreated Metastatic Colorectal Cancer (PRECONNECT)
Lead sponsor
Institut de Recherches Internationales Servier
Phase
Phase 3
Overall status
Completed
Start date
October 18, 2016
Completion date
November 30, 2020
Enrollment
907 (actual)
Sites
99

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer